Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. The company is developing a unique and proprietary Click-to-Release platform to enable selective release of anticancer drugs in the tumor microenvironment. This platform has a broad set of application areas (antidrug conjugates, radioligands, T cell engagers and cytokines), and has the potential to increase antitumor efficacy while lowering potential toxicity for patients.
Tagworks Pharmaceuticals raised a €60 million Series A financing co-led by Gilde Healthcare to further develop its differentiated click chemistry platform and bring drug candidates to the clinic.
More Tagworks news
Tagworks Pharmaceuticals announces $64 Million in Series A financing co-led by Gilde Healthcare
CatalYm
CatalYm is a clinical-stage immuno-oncology company improving the outcomes of existing checkpoint inhibitor therapies in...

Calypso Biotech
Dutch Therapeutics company focused on severe (auto) immune diseases.

Vapotherm
US-based MedTech company commercializing oxygen therapy for patients in respiratory distress.
